Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22748 | 314 | 39.1 | 95% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ICOS | Author keyword | 24 | 38% | 16% | 51 |
| 2 | B7RP 1 | Author keyword | 23 | 100% | 3% | 10 |
| 3 | ICOSL | Author keyword | 6 | 71% | 2% | 5 |
| 4 | INDUCIBLE COSTIMULATOR | Author keyword | 5 | 39% | 4% | 11 |
| 5 | B7H | Author keyword | 4 | 75% | 1% | 3 |
| 6 | PHARMACEUT FRONTIER S | Address | 4 | 20% | 5% | 16 |
| 7 | INDUCIBLE CO STIMULATOR | Author keyword | 3 | 60% | 1% | 3 |
| 8 | ICOSLG | Author keyword | 2 | 67% | 1% | 2 |
| 9 | AILIM ICOS | Author keyword | 1 | 100% | 1% | 2 |
| 10 | ICOS LIGAND | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ICOS | 24 | 38% | 16% | 51 | Search ICOS | Search ICOS |
| 2 | B7RP 1 | 23 | 100% | 3% | 10 | Search B7RP+1 | Search B7RP+1 |
| 3 | ICOSL | 6 | 71% | 2% | 5 | Search ICOSL | Search ICOSL |
| 4 | INDUCIBLE COSTIMULATOR | 5 | 39% | 4% | 11 | Search INDUCIBLE+COSTIMULATOR | Search INDUCIBLE+COSTIMULATOR |
| 5 | B7H | 4 | 75% | 1% | 3 | Search B7H | Search B7H |
| 6 | INDUCIBLE CO STIMULATOR | 3 | 60% | 1% | 3 | Search INDUCIBLE+CO+STIMULATOR | Search INDUCIBLE+CO+STIMULATOR |
| 7 | ICOSLG | 2 | 67% | 1% | 2 | Search ICOSLG | Search ICOSLG |
| 8 | AILIM ICOS | 1 | 100% | 1% | 2 | Search AILIM+ICOS | Search AILIM+ICOS |
| 9 | ICOS LIGAND | 1 | 100% | 1% | 2 | Search ICOS+LIGAND | Search ICOS+LIGAND |
| 10 | INDUCIBLE COSTIMULATOR ICOS | 1 | 50% | 1% | 2 | Search INDUCIBLE+COSTIMULATOR+ICOS | Search INDUCIBLE+COSTIMULATOR+ICOS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MOLECULE ICOS | 130 | 77% | 28% | 89 |
| 2 | PROTEIN ICOS | 33 | 100% | 4% | 13 |
| 3 | INDUCIBLE COSTIMULATOR | 29 | 37% | 20% | 64 |
| 4 | ICOS | 24 | 32% | 20% | 63 |
| 5 | B7H | 18 | 89% | 3% | 8 |
| 6 | ICOS LIGAND | 13 | 67% | 4% | 12 |
| 7 | AILIM ICOS | 12 | 86% | 2% | 6 |
| 8 | CO STIMULATION | 10 | 16% | 19% | 60 |
| 9 | B7RP 1 | 8 | 75% | 2% | 6 |
| 10 | INDUCIBLE COSTIMULATORY MOLECULE | 6 | 100% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS) | 2010 | 58 | 55 | 56% |
| The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency | 2009 | 22 | 123 | 49% |
| Emerging paradigms of T-cell co-stimulation | 2004 | 78 | 49 | 33% |
| The right place at the right time: novel B7 family members regulate effector T cell responses | 2002 | 91 | 44 | 64% |
| Regulation of T : B cell interactions by the Inducible Costimulator molecule: Does ICOS "induce" disease? | 2006 | 20 | 55 | 51% |
| CD28 and ICOS: Similar or separate costimulators of T cells? | 2006 | 27 | 89 | 42% |
| ICOS: A new costimulatory ligand/receptor pair and its role in T-cell activion | 2004 | 8 | 32 | 75% |
| Induced costimulatory molecule-B7h costimulatory pathway in alloirnmune regulation | 2005 | 0 | 28 | 71% |
| Critical co-stimulatory pathways in the stability of Foxp3(+) T-reg cell homeostasis in Type I Diabetes | 2011 | 13 | 106 | 17% |
| The expanding world of co-stimulation: the two-signal model revisited | 2001 | 143 | 63 | 29% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PHARMACEUT FRONTIER S | 4 | 20% | 5.1% | 16 |
| 2 | PULM ALLERGY CRIT CARE SECT | 1 | 50% | 0.6% | 2 |
| 3 | SHANGHAI THORAC TUMOR | 1 | 50% | 0.6% | 2 |
| 4 | INTERDISCIPLINARY AUTOIMMUNE DIS | 1 | 11% | 2.9% | 9 |
| 5 | ARTIFICIAL ORGAN TRANSPLANTAT SURG | 1 | 17% | 1.3% | 4 |
| 6 | HUMAN IMMUNOL UNITNUFFIELD CLIN MED | 1 | 50% | 0.3% | 1 |
| 7 | MED REGA IMMUNOBIOL | 1 | 50% | 0.3% | 1 |
| 8 | MUCOSAL IMMUNOL PHARMACOL | 1 | 50% | 0.3% | 1 |
| 9 | PHARMACEUT FRONTIER | 1 | 17% | 1.0% | 3 |
| 10 | DISCIPLINE INFECT IMMUN | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000254637 | CD28//CD80//B7 |
| 2 | 0.0000228310 | B7 H4//PD 1//PD L1 |
| 3 | 0.0000226127 | INTERLEUKIN 21//IL 21//FOLLICULAR HELPER T CELLS |
| 4 | 0.0000158914 | CTLA 4//IPILIMUMAB//CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 |
| 5 | 0.0000109043 | COSTIMULATION BLOCKADE//EMORY TRANSPLANT//MIXED CHIMERISM |
| 6 | 0.0000101724 | 4 1BB//OX40//CD137 |
| 7 | 0.0000078028 | TL 2 RESPONSE//ADCC REACTION//ANTI IG DEXTRAN |
| 8 | 0.0000070681 | T BET//GATA 3//HELPER T CELL DIFFERENTIATION |
| 9 | 0.0000048715 | URTICA DENTATA HAND//TOLEROGENIC DENDRITIC CELLS//IMMUNOL GEN SURG |
| 10 | 0.0000047097 | FOXP3//REGULATORY T CELLS//REGULATORY T CELL |